Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Syntocinon alone versus Syntocinon + Gymiso for blood loss after delivery
2006-005113-35Phase 3Completed
- Sponsor
- CHU de Limoges
- Start
- Jan 2007
- Modality
- Recombinant Proteins and Enzymes, Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of Misotac and oxytocin in postpartum hemorrhage (PPH) (2 arms), sponsored by CHU de Limoges. Primary endpoint: Quantity of blood loss. Started Jan 2007; status: completed.
02
Drugs
Misotacoxytocin
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on 2006-005113-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005113-35.